A study of antitumor (phase II) and immunosuppressive effects of ICRF-159 in patients with metastatic melanoma

A study of antitumor (phase II) and immunosuppressive effects of ICRF-159 in patients with metastatic melanoma

Saved in:
Bibliographic Details
Published in:Journal of clinical pharmacology Vol. 16; no. 8-9; p. 433
Main Authors: Bellet, R E, Catalano, R B, Danna, V G, Berd, D A, Berkelhammer, J, Mastrangelo, M J
Format: Journal Article
Language:English
Published: England 01-08-1976
Subjects:
Adult
Aged
Clinical Trials as Topic
Female
Humans
Immunosuppressive Agents - pharmacology
Male
Melanoma - drug therapy
Middle Aged
Neoplasm Metastasis
Piperazines - therapeutic use
Razoxane - adverse effects
Razoxane - pharmacology
Razoxane - therapeutic use
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0091-2700
DOI:10.1002/j.1552-4604.1976.tb02418.x